Y-mAbs Therapeutics Inc (YMAB)
17.32
+0.06
(+0.35%)
USD |
NASDAQ |
May 03, 11:38
Y-mAbs Therapeutics Total Liabilities (Quarterly): 26.88M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.88M |
| September 30, 2023 | 28.73M |
| June 30, 2023 | 27.72M |
| March 31, 2023 | 29.62M |
| December 31, 2022 | 32.24M |
| September 30, 2022 | 36.02M |
| June 30, 2022 | 33.78M |
| March 31, 2022 | 33.58M |
| December 31, 2021 | 32.68M |
| September 30, 2021 | 29.13M |
| June 30, 2021 | 25.16M |
| March 31, 2021 | 22.70M |
| Date | Value |
|---|---|
| December 31, 2020 | 26.21M |
| September 30, 2020 | 26.68M |
| June 30, 2020 | 21.32M |
| March 31, 2020 | 18.74M |
| December 31, 2019 | 17.46M |
| September 30, 2019 | 17.74M |
| June 30, 2019 | 17.66M |
| March 31, 2019 | 14.48M |
| December 31, 2018 | 11.40M |
| September 30, 2018 | 11.37M |
| June 30, 2018 | 7.777M |
| December 31, 2017 | 9.975M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.46M
Minimum
Dec 2019
36.02M
Maximum
Sep 2022
26.53M
Average
26.88M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| The Cooper Companies Inc | 4.337B |
| Puma Biotechnology Inc | 177.09M |
| Humacyte Inc | 114.68M |
| Moderna Inc | 4.572B |
| NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.87M |
| Shareholders Equity (Quarterly) | 100.98M |
| Current Ratio | 5.520 |